2020
DOI: 10.3892/etm.2020.8545
|View full text |Cite
|
Sign up to set email alerts
|

Role of Pneumocystis jirovecii infection in chronic obstructive pulmonary disease progression in an immunosuppressed rat Pneumocystis pneumonia model

Abstract: Pneumocystis jirovecii (P. jirovecii), an opportunistic fungal pathogen, is the primary cause of Pneumocystis pneumonia (PCP), which affects immunocompromised individuals and leads to high morbidity and mortality. P. jirovecii colonization is associated with development of chronic obstructive pulmonary disease (COPD) in patients with HIV infection, and also non-sufferers, and in primate models of HIV infection. However, the mechanisms underlying P. jirovecii infection in the pathogenesis of COPD have yet to be… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 40 publications
(47 reference statements)
1
4
0
Order By: Relevance
“…The increment of inflammation and emphysema lesions is similar with previous reports described in COPD patients, where Pneumocystis colonization increases the severity of COPD disease in HIV and non-HIV patients [34,42], supporting the hypothesis that Pneumocystis is a co-factor in chronic inflammatory lung diseases [37]. Interestingly, a recent work documented the role of Pneumocystis in the development of COPD disease in immunosuppressed animals [43], indicating a novel function of this fungus in the origin of the COPD disease. The inflammation is a hallmark in COPD that leads to mucus hypersecretion, fibrosis and airway collapse due pulmonary emphysema that is associated to the severity of the disease [2].…”
Section: Discussionsupporting
confidence: 88%
“…The increment of inflammation and emphysema lesions is similar with previous reports described in COPD patients, where Pneumocystis colonization increases the severity of COPD disease in HIV and non-HIV patients [34,42], supporting the hypothesis that Pneumocystis is a co-factor in chronic inflammatory lung diseases [37]. Interestingly, a recent work documented the role of Pneumocystis in the development of COPD disease in immunosuppressed animals [43], indicating a novel function of this fungus in the origin of the COPD disease. The inflammation is a hallmark in COPD that leads to mucus hypersecretion, fibrosis and airway collapse due pulmonary emphysema that is associated to the severity of the disease [2].…”
Section: Discussionsupporting
confidence: 88%
“…These results support the idea that this fungus may be a new element that triggers pathological processes in chronic respiratory diseases, leading to an increment of the severity of the symptoms. Moreover, the role of Pneumocystis has been proposed as a key factor in the first steps of the development of COPD using immunosuppressed animals [ 41 ]. In addition, studies of human COPD patients infected with Pneumocystis jirovecii (the causative agent of human Pneumocystis infection) showed that the detection of this fungus correlates with higher pro-inflammatory cytokines levels, such as TNFα, IL6, and IL8 [ 32 ].…”
Section: Discussionmentioning
confidence: 99%
“…Infected BALF EVs also include proteins involved in stress response and immune system processes, such as heat shock proteins. Heat shock proteins have been shown to be upregulated in A549 lung epithelial cells treated with P. carinii , in the lungs of Pneumocystis infection in rats, and in animal models of lung injury ( 37 39 ). The specific host-pathogen interactions of these host vesicles and their cargo with P. carinii and P. murina are currently unknown.…”
Section: Discussionmentioning
confidence: 99%